Literature DB >> 7660673

Prostatic intraepithelial neoplasia: a potential precursor lesion of prostatic adenocarcinoma.

H J Shin1, J Y Ro.   

Abstract

The necessity of early detection of prostate cancer renewed interest regarding putative premalignant lesions in the tumorigenesis of the prostate. Prostatic intraepithelial neoplasia (PIN) is one potential precursor for prostatic adenocarcinoma. The term PIN has been adopted to replace a wide range of synonyms in the literature that describe potential precursors. PIN is an intraluminal proliferation of the secretory cells lining architecturally benign prostatic ducts and acini that exhibit cytologic atypia. In this review, we discuss the histologic features, the differential diagnosis, the evidence that PIN is a precursor of prostatic carcinoma, and the clinical significance of PIN.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7660673     DOI: 10.3349/ymj.1995.36.3.215

Source DB:  PubMed          Journal:  Yonsei Med J        ISSN: 0513-5796            Impact factor:   2.759


  4 in total

1.  Metformin targets c-MYC oncogene to prevent prostate cancer.

Authors:  Tunde Akinyeke; Satoko Matsumura; Xinying Wang; Yingjie Wu; Eric D Schalfer; Anjana Saxena; Wenbo Yan; Susan K Logan; Xin Li
Journal:  Carcinogenesis       Date:  2013-10-15       Impact factor: 4.944

2.  Neoplastic disorders of prostate glands in the light of synchrotron radiation and multivariate statistical analysis.

Authors:  A Banas; K Banas; W M Kwiatek; M Gajda; B Pawlicki; T Cichocki
Journal:  J Biol Inorg Chem       Date:  2011-06-26       Impact factor: 3.358

Review 3.  Importance of Estrogenic Signaling and Its Mediated Receptors in Prostate Cancer.

Authors:  Kin-Mang Lau; Ka-Fai To
Journal:  Int J Mol Sci       Date:  2016-08-31       Impact factor: 5.923

Review 4.  Metformin: A Bridge between Diabetes and Prostate Cancer.

Authors:  Veronica Zingales; Alfio Distefano; Marco Raffaele; Antonio Zanghi; Ignazio Barbagallo; Luca Vanella
Journal:  Front Oncol       Date:  2017-10-11       Impact factor: 6.244

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.